Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeuroVasx seeks US market nod for CPAX aneurysm-filling polymer:

This article was originally published in Clinica

Executive Summary

NeuroVasx has filed a 510(k) marketing application with the US FDA for its cerebral aneurysm-filling technology. cPAX comprises a polymeric strand that is delivered minimally-invasively through a microcatheter into the aneurysm over a guide wire. The product consists of a soft, flexible material, which allows for increased packing density, said the Maple Grove, Minnesota firm. According to the company, the worldwide market potential for stroke treatment devices is estimated to be over $3bn.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048960

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel